Ledger.Open graph →
SEC Form D · filed May 20, 2021

Adaptive Phage Therapeutics, Inc

Offering
$53.3M
Sold
$23.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GAITHERSBURG, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Gregory L. Merril · Gaithersburg, MDExec · Director · PromoterRaymond L. Martz · Gaithersburg, MDDirectorCarl R. Merril · Gaithersburg, MDExec · DirectorEvan L. Loh · Gaithersburg, MDDirectorJonathan L. Leff · Gaithersburg, MDDirectorJana L. Jensen · Gaithersburg, MDDirectorEvan L. Loh · Gaithersburg, MDDirectorGregory L. Merril · Gaithersburg, MDExec · Director · PromoterJonathan L. Leff · Gaithersburg, MDDirectorJana L. Jensen · Gaithersburg, MDDirectorRaymond L. Martz · Gaithersburg, MDDirectorCarl R. Merril · Gaithersburg, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗